St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
Hormone boost plus chemo aims to shrink hard-to-treat prostate cancer
Disease control Recruiting nowThis study tests whether a high dose of testosterone combined with the chemotherapy drug carboplatin can help men with a specific type of advanced prostate cancer that has stopped responding to standard hormone therapy. About 30 men with a genetic defect called homologous recombi…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-phase study tests whether adding a new drug (roginolisib) to an existing treatment (tebentafusp) is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer. The study enrolls 8 adults who are already receiving tebentafusp as their first treatment.…
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
What do men think about breast side effects from prostate cancer treatment?
Knowledge-focused Recruiting nowThis study talks to men with prostate cancer to learn how they feel about the risk of breast-related side effects, like breast growth (gynecomastia), from their treatment. Researchers will interview 24 men to understand their views and what trade-offs they are willing to make. Th…
Phase: NA • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 17, 2026 07:45 UTC